Statement of Organization, Functions and Delegations of Authority, 20293 [E8-7855]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 73 / Tuesday, April 15, 2008 / Notices
Dated: April 9, 2008.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E8–7986 Filed 4–14–08; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
Statement of Organization, Functions
and Delegations of Authority
Part J (Agency for Toxic Substances
and Disease Registry) of the Statement
of Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (50 FR 25129–25130, dated
June 17, 1985, as amended most
recently at 71 FR 58396–5 8397, dated
October 3, 2006) is amended to reflect
the reorganization of the Office of the
Director, Agency for Toxic Substances
and Disease Registry.
Section J–B, Organization and
Functions, is hereby amended as
follows:
After item (9) of the functional
statement for the Office of the Director
(JAA), Agency for Toxic Substances and
Disease Registry (J), add the following:
(10) serves as primary liaison between
ATSDR and the National Center for
Health Marketing on communications
and marketing science, and its
associated research and practice.
Delete in their entirety the title and
functional statement for the Office of
Communications (JAA4).
Dated: April 2, 2008.
Joseph Henderson,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E8–7855 Filed 4–14–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–08AW]
jlentini on PROD1PC65 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
17:31 Apr 14, 2008
Jkt 214001
Proposed Project
Quarantine Station Illness Response
Forms—Airline, Maritime, Land/Border
Crossing—New—National Center for
Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID), Centers
for Disease Control and Prevention
(CDC).
CDC proposes to collect patient-level
clinical, epidemiologic, and
demographic data from ill travelers and
their possible contacts in order to fulfill
its regulatory responsibility to prevent
the importation of communicable
diseases from foreign countries (42 CFR
Part 71) and interstate control of
communicable diseases in humans (42
CFR Part 70).
Background and Brief Description
BILLING CODE 4160–70–M
VerDate Aug<31>2005
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road,
NE., MS-D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarify of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of information technology. Written
comments should be received within 60
days of this notice.
Section 361 of the Public Health
Service (PHS) Act (42 U.S.C. 264)
authorizes the Secretary of Health and
Human Services to make and enforce
regulations necessary to prevent the
introduction, transmission or spread of
communicable diseases from foreign
countries into the United States. The
regulations that implement this law, 42
CFR Parts 70 and 71, authorize
quarantine officers and other personnel
to inspect and undertake necessary
control measures with respect to
conveyances (e.g., airplanes, cruise
ships, trucks, etc.), persons, and
shipments of animals and etiologic
agents in order to protect the public
health. The regulations also require
conveyances to immediately report an
‘‘ill person’’ or any death on board to
the Quarantine Station prior to arrival in
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
20293
the United States. An ‘‘ill person’’ is
defined in statute by:
—Fever (≥100 °F or 38 °C) persisting ≥48
hours
—Fever (≥100 °F or 38 °C) AND rash,
glandular swelling, or jaundice
—Diarrhea (≥3 stools in 24 hours or
greater than normal amount)
The SARS situation and concern
about pandemic influenza and other
communicable diseases have prompted
CDC Quarantine Stations to recommend
that all illnesses be reported prior to
arrival.
CDC Quarantine Stations are currently
located at 20 international U.S. Ports of
Entry. When a suspected illness is
reported to the Quarantine Station,
officers promptly respond to this report
by meeting the incoming conveyance
(when possible), collecting information
and evaluating the patient(s), and
determining whether an ill person can
safely be admitted into the U.S. If
Quarantine Station staff are unable to
meet the conveyance, the crew or
medical staff of the conveyance are
trained to complete the required
documentation and forward it (using a
secure system) to the Quarantine Station
for review and follow-up.
To perform these tasks in a
streamlined manner and ensure that all
relevant information is collected in the
most efficient and timely manner
possible, Quarantine Stations use a
number of forms—the Airline Screening
and Illness Response Form, the Ship
Illness/Death Reporting Form, and the
Land/Border Crossing Form—to collect
data on passengers with suspected
illness and other travelers/crew who
may have been exposed to an illness.
These forms are also used to respond to
a report of a death aboard a conveyance.
The purpose of all three forms is the
same: to collect information that helps
quarantine officials detect and respond
to potential public health
communicable disease threats. All three
forms collect the following categories of
information: Demographics and mode of
transportation, clinical and medical
history, and any other relevant facts
(e.g., travel history, traveling
companions, etc.). As part of this
documentation, quarantine public
health officers look for specific signs
and symptoms common to the nine
quarantinable diseases (Pandemic
influenza; SARS; Cholera; Plague;
Diphtheria; Infectious Tuberculosis;
Smallpox; Yellow fever; and Viral
Hemorrhagic Fevers), as well as most
communicable diseases in general.
These signs and symptoms include
fever, difficulty breathing, shortness of
breath, cough, diarrhea, jaundice, or
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 73, Number 73 (Tuesday, April 15, 2008)]
[Notices]
[Page 20293]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7855]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
Statement of Organization, Functions and Delegations of Authority
Part J (Agency for Toxic Substances and Disease Registry) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (50 FR 25129-25130, dated
June 17, 1985, as amended most recently at 71 FR 58396-5 8397, dated
October 3, 2006) is amended to reflect the reorganization of the Office
of the Director, Agency for Toxic Substances and Disease Registry.
Section J-B, Organization and Functions, is hereby amended as
follows:
After item (9) of the functional statement for the Office of the
Director (JAA), Agency for Toxic Substances and Disease Registry (J),
add the following: (10) serves as primary liaison between ATSDR and the
National Center for Health Marketing on communications and marketing
science, and its associated research and practice.
Delete in their entirety the title and functional statement for the
Office of Communications (JAA4).
Dated: April 2, 2008.
Joseph Henderson,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8-7855 Filed 4-14-08; 8:45 am]
BILLING CODE 4160-70-M
